ArticleJournal of cancer research and clinical oncology2023

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.

Guangchao Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.